FDA Warning Letter — BP/ Kangaroo Express

Case 523093 — FEI 3013434756

The FDA took a Warning Letter action against BP/ Kangaroo Express on Apr 20, 2017 (Surfside Beach, SC). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP/ Kangaroo Express
Date
Apr 20, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Surfside Beach, SC (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.